Cardiotoxicity in childhood cancer survivors: strategies for prevention and management - Wikidata - awgldk - TriplyDB

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

http://www.wikidata.org/entity/Q24628695

about

The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure Sulforaphane protects the heart from doxorubicin-induced toxicity Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment.Late Cardiotoxicity in Aging Adult Survivors of Childhood Cancer.Pharmacogenomics and adverse drug reactions in children.Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.Survivorship.Prevention of cardiotoxicity among survivors of childhood cancer.Cardiovascular disease in cancer survivors.Automated Functional Imaging by 2D Speckle Tracking Echocardiography Reveals High Incidence of Abnormal Longitudinal Strain in a Cohort of Pediatric Oncology Patients.Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary Cardiovascular medication after cancer at a young age in Finland: A nationwide registry linkage study.Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway.Acute adriamycin-induced cardiotoxicity is exacerbated by angiotension II Rutin Protects against Pirarubicin-Induced Cardiotoxicity through TGF-β1-p38 MAPK Signaling Pathway.Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats.Quercetin Reverses Altered Energy Metabolism in the Heart of Rats Receiving Adriamycin Chemotherapy.The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity.Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.Heart failure following blood cancer therapy in pediatric and adult populations.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors.Developing a Reliable Mouse Model for Cancer Therapy-Induced Cardiovascular Toxicity in Cancer Patients and Survivors.

P2860

Q26823592-5A347CF9-6C9F-4D1B-BCFC-6EEF57452229 Q28387218-564E448E-AD36-4969-8BA0-5D3ABDA92D41 Q32178695-EE67F01D-68B5-47CC-B41C-38F15C7AC4F7 Q33658456-8899F484-F295-4A8D-AF0C-86F26699DA8F Q35657024-90D4648C-4157-4732-BE98-917758E081E4 Q36087880-6802022A-22D2-4639-9D29-1AAA0E9D44B8 Q37719025-E132E820-1368-4CB4-8E9C-FB8B434EA72F Q38079197-B97110C0-EC48-406F-A214-98ADA20960D6 Q38306995-C30E1543-B774-4BB3-AAF6-0F7A5FCFE329 Q38824644-61605F07-827A-4E1F-A8A9-CBF8A524F811 Q39103481-50B6E5FB-93B5-464C-A58A-9FD2A5178938 Q40006876-E7A21F2E-A645-4863-BF62-6356EC52AD59 Q40262668-ABE6EB80-FBF6-46DF-B3CC-B71C277433D7 Q41082970-BDECEF35-29CC-40C7-AA83-A880A500A8C9 Q41094773-DA4F15FB-1DF7-41C1-B590-191E638AE94F Q41167751-404A466A-58A3-4450-9FED-BD9D2AC9A5AC Q41376836-5C148AAA-1AEC-43EA-8BD9-B4A5B5001C3D Q41825099-51916ED4-665F-4C7C-B8AB-14F0EB86C4BE Q43151456-659A24F2-481B-4F23-B081-51F69D473F32 Q46827590-BA772CDC-95D7-432A-B636-B3F93719A377 Q46935336-899E9BF6-E606-48EA-9F91-556F592E33EC Q47290040-EB09A35C-B546-4135-8E8E-7606BC511332 Q47784022-420136DD-8998-4CD4-AE02-8DC24FEE1C84 Q47811419-DF43997E-6032-4B48-94D4-4FB59911D4A1 Q48331843-4EC5EA9B-2AFD-4F87-A323-998C63B4D5AB Q51105427-BA429F10-AB68-407D-A36E-26129B33B3DE Q54941414-4EF150F9-DBC8-4012-B6FA-353703E90DED

P2860

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

http://www.wikidata.org/entity/Q24628695

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@ast

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@en

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@nl

type

label

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@ast

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@en

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@nl

prefLabel

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@ast

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@en

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@nl

P1433

Q24628695-5534F635-B740-48A3-B073-1BBCF1A75DB0

P1476

Q24628695-AC370283-2D8E-47AD-93B7-8061D2E7A3FF

P2093

Q24628695-0146DD08-0587-4CA5-97DD-3078E64CF2CF

Q24628695-6BEE3AAC-2B90-449B-BA29-2ABF1E03A71E

Q24628695-7D7E393B-4323-4A73-AAEB-76381143DCAA

Q24628695-AEE739D1-AE49-4C55-BC22-651A2C2AFF9A

P2860

Q24628695-0091E075-389C-4D5A-B4E1-276AD28898A3

Q24628695-0124CD6D-76DC-40BC-BD1F-E70637F0F6EC

Q24628695-05C73451-5AC1-41B6-811B-A1D4FD20402E

Q24628695-0708585F-4FF4-428F-AF8D-78148809BC40

Q24628695-08022AF8-8F66-4D92-954F-E990047D4EF6

Q24628695-08A317DE-106F-4918-9FA4-80872E2BEB81

Q24628695-0938C613-8E79-4B27-B11F-101762A7F736

Q24628695-09D5E8F6-BD7A-4D83-8D98-5634E5EC1ECF

Q24628695-0A0ED792-0073-4E2A-AAED-C68DBF1132E8

Q24628695-0B2BC5F8-C744-4E1B-9D4D-1039B5DCF76B

P304

Q24628695-02F0D4E3-3FB3-4A3A-9662-3C40985B114E

P31

Q24628695-6265E7F7-6B68-4680-ACA7-C47327098509

P356

Q24628695-DADB9874-9094-440A-96CB-38204C7D8A45

P407

Q24628695-32CA4A2D-0E8E-4C56-8C9E-E7E807C68D70

P433

Q24628695-C3AF9248-887C-4790-A169-DABD7DD8F52D

P478

Q24628695-63CC90F0-332D-4CCA-8022-A2B6011DBC84

P50

Q24628695-4056AA41-3EE7-44B6-A5C3-D62A744E8D82

P577

Q24628695-45C30B4A-582D-4503-B45D-95186E68DA6A

P698

Q24628695-4B69C3C9-6298-4423-B7AA-8A38F4CDF718

P932

Q24628695-C166F9BA-893E-4BE9-8CFD-0247C9E346CC

P356

P1433

Future Cardiology

P1476

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

@en

P2093

Danielle Harake

http://www.w3.org/2001/XMLSchema#string

Jacqueline M Henkel

http://www.w3.org/2001/XMLSchema#string

Tracie L Miller

http://www.w3.org/2001/XMLSchema#string

Vivian I Franco

http://www.w3.org/2001/XMLSchema#string

P2860

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

Cardioprotective interventions for cancer patients receiving anthracyclines

The role of the novel adipocyte-derived hormone adiponectin in human disease

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

The anthracyclines: will we ever find a better doxorubicin?

Cyclic nucleotide phosphodiesterases

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

P304

647-670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.12.44

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Steven E Lipshultz

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22871201

http://www.w3.org/2001/XMLSchema#string

P932

3870660

http://www.w3.org/2001/XMLSchema#string